193 related articles for article (PubMed ID: 33707557)
1. Exploring genetic alterations in circulating tumor DNA from cerebrospinal fluid of pediatric medulloblastoma.
Sun Y; Li M; Ren S; Liu Y; Zhang J; Li S; Gao W; Gong X; Liu J; Wang Y; Du S; Sun L; Wu W; Tian Y
Sci Rep; 2021 Mar; 11(1):5638. PubMed ID: 33707557
[TBL] [Abstract][Full Text] [Related]
2. Detection of tumor-derived cell-free DNA in cerebrospinal fluid using a clinically validated targeted sequencing panel for pediatric brain tumors.
Ronsley R; Karvonen KA; Cole B; Paulson V; Stevens J; Crotty EE; Hauptman J; Lee A; Stasi SM; Lockwood CM; Leary SES
J Neurooncol; 2024 Jun; 168(2):215-224. PubMed ID: 38755519
[TBL] [Abstract][Full Text] [Related]
3. Reliable tumor detection by whole-genome methylation sequencing of cell-free DNA in cerebrospinal fluid of pediatric medulloblastoma.
Li J; Zhao S; Lee M; Yin Y; Li J; Zhou Y; Ballester LY; Esquenazi Y; Dashwood RH; Davies PJA; Parsons DW; Li XN; Huang Y; Sun D
Sci Adv; 2020 Oct; 6(42):. PubMed ID: 33067228
[TBL] [Abstract][Full Text] [Related]
4. Disease Evolution Monitored by Serial Cerebrospinal Fluid Liquid Biopsies in Two Cases of Recurrent Medulloblastoma.
O'Halloran K; Margol A; Davidson TB; Estrine D; Tamrazi B; Cotter JA; Ji J; Biegel JA
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732099
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma.
Escudero L; Llort A; Arias A; Diaz-Navarro A; Martínez-Ricarte F; Rubio-Perez C; Mayor R; Caratù G; Martínez-Sáez E; Vázquez-Méndez É; Lesende-Rodríguez I; Hladun R; Gros L; Ramón Y Cajal S; Poca MA; Puente XS; Sahuquillo J; Gallego S; Seoane J
Nat Commun; 2020 Oct; 11(1):5376. PubMed ID: 33110059
[TBL] [Abstract][Full Text] [Related]
6. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies.
Liu APY; Smith KS; Kumar R; Paul L; Bihannic L; Lin T; Maass KK; Pajtler KW; Chintagumpala M; Su JM; Bouffet E; Fisher MJ; Gururangan S; Cohn R; Hassall T; Hansford JR; Klimo P; Boop FA; Stewart CF; Harreld JH; Merchant TE; Tatevossian RG; Neale G; Lear M; Klco JM; Orr BA; Ellison DW; Gilbertson RJ; Onar-Thomas A; Gajjar A; Robinson GW; Northcott PA
Cancer Cell; 2021 Nov; 39(11):1519-1530.e4. PubMed ID: 34678152
[TBL] [Abstract][Full Text] [Related]
7. Plasma ctDNA Monitoring of a PTCH1-Mutant Metastatic Adult Medulloblastoma Showing a Durable Benefit With Vismodegib.
Cabezas-Camarero S; García-Barberán V; Pérez-Alfayate R; Gómez Del Pulgar ME; Cabrera-Martin MN; Casado-Fariñas I; Pérez-Segura P
Oncologist; 2024 May; 29(5):377-383. PubMed ID: 38438322
[TBL] [Abstract][Full Text] [Related]
8. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid cytokines in metastatic group 3 and 4 medulloblastoma.
Low SYY; Bte Syed Sulaiman N; Tan EEK; Ng LP; Kuick CH; Chang KTE; Tang PH; Wong RX; Looi WS; Low DCY; Seow WT
BMC Cancer; 2020 Jun; 20(1):554. PubMed ID: 32539808
[TBL] [Abstract][Full Text] [Related]
10. Different next-generation sequencing pipelines based detection of tumor DNA in cerebrospinal fluid of lung adenocarcinoma cancer patients with leptomeningeal metastases.
Ge M; Zhan Q; Zhang Z; Ji X; Zhou X; Huang R; Liang X
BMC Cancer; 2019 Feb; 19(1):143. PubMed ID: 30755180
[TBL] [Abstract][Full Text] [Related]
11. Young investigator challenge: Cytomorphologic analysis of cerebrospinal fluid in 70 pediatric patients with medulloblastoma and review of the literature focusing on novel diagnostic and prognostic tests.
Damiani D; Suciu V; Andreiuolo F; Calderaro J; Vielh P
Cancer Cytopathol; 2015 Nov; 123(11):644-9. PubMed ID: 26769585
[TBL] [Abstract][Full Text] [Related]
12. Proteome and miRNome profiling of microvesicles derived from medulloblastoma cell lines with stem-like properties reveals biomarkers of poor prognosis.
Kaid C; Assoni A; Marçola M; Semedo-Kuriki P; Bortolin RH; Carvalho VM; Okamoto OK
Brain Res; 2020 Mar; 1730():146646. PubMed ID: 31917138
[TBL] [Abstract][Full Text] [Related]
13. Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma.
Bruzek AK; Ravi K; Muruganand A; Wadden J; Babila CM; Cantor E; Tunkle L; Wierzbicki K; Stallard S; Dickson RP; Wolfe I; Mody R; Schwartz J; Franson A; Robertson PL; Muraszko KM; Maher CO; Garton HJL; Qin T; Koschmann C
Clin Cancer Res; 2020 Dec; 26(23):6266-6276. PubMed ID: 33087334
[TBL] [Abstract][Full Text] [Related]
14. Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patients.
Miller AM; Szalontay L; Bouvier N; Hill K; Ahmad H; Rafailov J; Lee AJ; Rodriguez-Sanchez MI; Yildirim O; Patel A; Bale TA; Benhamida JK; Benayed R; Arcila ME; Donzelli M; Dunkel IJ; Gilheeney SW; Khakoo Y; Kramer K; Sait SF; Greenfield JP; Souweidane MM; Haque S; Mauguen A; Berger MF; Mellinghoff IK; Karajannis MA
Neuro Oncol; 2022 Oct; 24(10):1763-1772. PubMed ID: 35148412
[TBL] [Abstract][Full Text] [Related]
15. Recurrent Cerebellar Desmoplastic/Nodular Medulloblastoma in Cerebrospinal Fluid (CSF) in the Elderly. A Cytologic Diagnosis.
Kalogeraki A; Tamiolakis D; Mavrigiannaki P; Karvelaskalogerakis M; Datseri G; Agelaki S; Papadopoulos S
Rom J Intern Med; 2016; 54(2):137-9. PubMed ID: 27352444
[TBL] [Abstract][Full Text] [Related]
16. A nanowire-based liquid biopsy method using cerebrospinal fluid cell-free DNA for targeted management of leptomeningeal carcinomatosis.
Choi W; Cho Y; Park SY; Hwang KH; Han JY; Lee Y
J Cancer Res Clin Oncol; 2021 Jan; 147(1):213-222. PubMed ID: 32705364
[TBL] [Abstract][Full Text] [Related]
17. Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas.
Hickmann AK; Frick M; Hadaschik D; Battke F; Bittl M; Ganslandt O; Biskup S; Döcker D
BMC Cancer; 2019 Mar; 19(1):192. PubMed ID: 30823914
[TBL] [Abstract][Full Text] [Related]
18. Assessment of ctDNA in CSF may be a more rapid means of assessing surgical outcomes than plasma ctDNA in glioblastoma.
Li JH; He ZQ; Lin FH; Chen ZH; Yang SY; Duan H; Jiang XB; Al-Nahari F; Zhang XH; Wang JH; Zhang GH; Zhang ZF; Li C; Mou YG
Mol Cell Probes; 2019 Aug; 46():101411. PubMed ID: 31173881
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid M staging for medulloblastoma: reappraisal of Chang's M staging based on the CSF flow.
Phi JH; Lee J; Wang KC; Cho BK; Kim IO; Park CK; Kim CY; Ahn HS; Kim IH; Kim SK
Neuro Oncol; 2011 Mar; 13(3):334-44. PubMed ID: 21134897
[TBL] [Abstract][Full Text] [Related]
20. Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies.
Momtaz P; Pentsova E; Abdel-Wahab O; Diamond E; Hyman D; Merghoub T; You D; Gasmi B; Viale A; Chapman PB
Oncotarget; 2016 Dec; 7(51):85430-85436. PubMed ID: 27863426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
